Strados Labs develops the RESP® Biosensor, a smart device that continuously captures lung sounds such as cough and wheeze, providing objective, time-stamped data for remote respiratory monitoring. This technology addresses the limitations of traditional auscultation and patient self-reporting, enhancing the management of chronic respiratory diseases and improving clinical trial insights.
Funding
$11.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of assessing patient lung health rely on in-person auscultation and subjective patient self-reporting, which are prone to recall bias and limited by the infrequency of clinic visits. This makes continuous, objective respiratory monitoring challenging, hindering effective management of chronic respiratory diseases and limiting insights in clinical trials.
Solution
Strados Labs offers the RESP® Biosensor, a wearable device that continuously captures lung sounds, including cough and wheeze, providing objective, time-stamped data for remote respiratory monitoring. The biosensor adheres to the patient's chest and transmits data via Bluetooth to a companion mobile app. The Strados™ Cloud securely stores the data, tracking and trending lung sound events to provide a comprehensive view of the patient's respiratory health. This end-to-end solution enhances the management of chronic respiratory diseases and offers improved insights into subject treatment response in clinical trials.
Target Audience
The primary users are healthcare providers managing patients with chronic respiratory diseases such as asthma, COPD, and pulmonary fibrosis, as well as pharmaceutical companies and clinical researchers conducting respiratory clinical trials.
Features
- Continuous capture of lung sounds, including cough and wheeze
- Wireless data transfer to a mobile app via Bluetooth
- Secure cloud storage for data trending and analysis
- Clinically validated accuracy against the Littman 3200 digital stethoscope
- Integration of end-to-end encryption and advanced noise filtering for patient data privacy
- Discreet, low-burden design for patient comfort and real-world data collection
- FDA 510(k) clearance and CE Mark